Stem Cell Therapy Improves Symptoms of Rheumatoid Arthritis
Mesenchymal stem cells are proving to have significant effects on a variety of autoimmune type of problems such as rheumatoid, osteoarthritis, Lupus, colitis, mixed connective tissue disease, scleroderma, etc. Good improvement in osteoarthritis has also been seen with the intravenous administration of primitive hematopoietic stem cells (CD34+CD133+).
In general, the best results are thought to occur with the direct administration of the cells directly into the joint(s) or immediately around the joint. Osteoarthritic joints where there is no longer cartilage have also shown improvement with administration of cord stem cells directly into the joint.
There are a number of advantages to using human umbilical cord stem cells that do not require immune suppression and which can help balance immune function by changing the genetics of the immune reactive cells. Several patients diagnosed with stroke or other conditions who received cord stem cells in Mexico reported that their arthritis pain subsided.
There is also an increased risk of cardiovascular disease in patients with active rheumatoid arthritis which may be in part due to reduced numbers of endothelial progenitor cells circulating in the peripheral blood. Providing cord stem cells to RA patients may help reduce cardiovascular risk as well as reduce joint damage.
In addition to stem cell therapies, the treatment of rheumatoid arthritis requires a comprehensive program that includes detoxification and nutritional therapies. In addition, there are also pulsating magnetic beds available that can stimulate bone remodeling and help to correct structural abnormalities associated with severe osteoarthritis of the spine. For research on arthritis, click here.
This information is presented for educational purposes only.